Status:
RECRUITING
Adult Pulmonary Langerhans Cell Histiocytosis: a National Registry-based Prospective Cohort Study
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Histiocytosis
Histiocytosis, Langerhans-Cell
Eligibility:
All Genders
18+ years
Brief Summary
The long-term outcomes of adult patients with pulmonary Langerhans cell histiocytosis (PLCH), particularly survival, is largely unknown. This is the first prospective study in the field evaluating the...
Eligibility Criteria
Inclusion
- Age \>= 18 years
- Diagnosis of PLCH was either histologically confirmed on a biopsy of an involved tissue, or based on the combination of the following criteria: 1) an appropriate clinical picture; 2) a typical nodulo-cystic pattern on lung high-resolution computed tomography (HRCT) and 3) exclusion of alternative diagnoses
Exclusion
- \-
Key Trial Info
Start Date :
January 1 2004
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2035
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04665674
Start Date
January 1 2004
End Date
December 31 2035
Last Update
December 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
French national reference centre for Histiocytoses
Paris, France, 75010